Literature DB >> 30305355

Defining HIV-1 Envelope N-Glycan Microdomains through Site-Specific Heterogeneity Profiles.

Audra A Hargett1, Qing Wei2, Barbora Knoppova2,3, Stacy Hall2, Zhi-Qiang Huang2, Amol Prakash4, Todd J Green2, Zina Moldoveanu2, Milan Raska2,3, Jan Novak5, Matthew B Renfrow6.   

Abstract

The HIV-1 envelope (Env) glycans shield the surface of Env from the immune system and form integral interactions important for a functional Env. To understand how individual N-glycosylation sites (NGS) coordinate to form a dynamic shield and evade the immune system through mutations, we tracked 20 NGS in Env from HIV-transmitted/founder (T/F) and immune escape variants and their mutants involving the N262 glycan. NGS were profiled in a site-specific manner using a high-resolution mass spectrometry (MS)-based workflow. Using this site-specific quantitative heterogeneity profiling, we empirically characterized the interdependent NGS of a microdomain in the high-mannose patch (HMP). The changes (shifts) in NGS heterogeneity between the T/F and immune escape variants defined a range of NGS that we further probed for exclusive combinations of sequons in the HMP microdomain using the Los Alamos National Laboratory HIV sequence database. The resultant sequon combinations, including the highly conserved NGS N262, N448, and N301, created an immune escape map of the conserved and variable sequons in the HMP microdomain. This report provides details on how some clustered NGS form microdomains that can be identified and tracked across Env variants. These microdomains have a limited number of N-glycan-sequon combinations that may allow the anticipation of immune escape variants.IMPORTANCE The Env protein of HIV is highly glycosylated, and the sites of glycosylation can change as the virus mutates during immune evasion. Due to these changes, the glycan location and heterogeneity of surrounding N-glycosylation sites can be altered, resulting in exposure of different glycan or proteoglycan surfaces while still producing a viable HIV variant. These changes present a need for vaccine developers to identify Env variants with epitopes most likely to induce durable protective responses. Here we describe a means of anticipating HIV-1 immune evasion by dividing Env into N-glycan microdomains that have a limited number of N-glycan sequon combinations.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  HIV-1 envelope; N-glycosylation; human immunodeficiency virus; mass spectrometry

Mesh:

Substances:

Year:  2018        PMID: 30305355      PMCID: PMC6288332          DOI: 10.1128/JVI.01177-18

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III.

Authors:  J S Allan; J E Coligan; F Barin; M F McLane; J G Sodroski; C A Rosen; W A Haseltine; T H Lee; M Essex
Journal:  Science       Date:  1985-05-31       Impact factor: 47.728

Review 2.  The joys of HexNAc. The synthesis and function of N- and O-glycan branches.

Authors:  H Schachter
Journal:  Glycoconj J       Date:  2000 Jul-Sep       Impact factor: 2.916

Review 3.  Glycosylation Quality Control by the Golgi Structure.

Authors:  Xiaoyan Zhang; Yanzhuang Wang
Journal:  J Mol Biol       Date:  2016-03-05       Impact factor: 5.469

4.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

5.  Cryo-EM structure of a native, fully glycosylated, cleaved HIV-1 envelope trimer.

Authors:  Jeong Hyun Lee; Gabriel Ozorowski; Andrew B Ward
Journal:  Science       Date:  2016-03-04       Impact factor: 47.728

6.  Promiscuous glycan site recognition by antibodies to the high-mannose patch of gp120 broadens neutralization of HIV.

Authors:  Devin Sok; Katie J Doores; Bryan Briney; Khoa M Le; Karen L Saye-Francisco; Alejandra Ramos; Daniel W Kulp; Jean-Philippe Julien; Sergey Menis; Lalinda Wickramasinghe; Michael S Seaman; William R Schief; Ian A Wilson; Pascal Poignard; Dennis R Burton
Journal:  Sci Transl Med       Date:  2014-05-14       Impact factor: 17.956

Review 7.  The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens.

Authors:  R Wyatt; J Sodroski
Journal:  Science       Date:  1998-06-19       Impact factor: 47.728

8.  Glycan clustering stabilizes the mannose patch of HIV-1 and preserves vulnerability to broadly neutralizing antibodies.

Authors:  Laura K Pritchard; Daniel I R Spencer; Louise Royle; Camille Bonomelli; Gemma E Seabright; Anna-Janina Behrens; Daniel W Kulp; Sergey Menis; Stefanie A Krumm; D Cameron Dunlop; Daniel J Crispin; Thomas A Bowden; Christopher N Scanlan; Andrew B Ward; William R Schief; Katie J Doores; Max Crispin
Journal:  Nat Commun       Date:  2015-06-24       Impact factor: 14.919

9.  Deletion of the highly conserved N-glycan at Asn260 of HIV-1 gp120 affects folding and lysosomal degradation of gp120, and results in loss of viral infectivity.

Authors:  Leen Mathys; Katrien O François; Matthias Quandte; Ineke Braakman; Jan Balzarini
Journal:  PLoS One       Date:  2014-06-26       Impact factor: 3.240

10.  Systematic analysis of mutation distribution in three dimensional protein structures identifies cancer driver genes.

Authors:  Akihiro Fujimoto; Yukinori Okada; Keith A Boroevich; Tatsuhiko Tsunoda; Hiroaki Taniguchi; Hidewaki Nakagawa
Journal:  Sci Rep       Date:  2016-05-26       Impact factor: 4.379

View more
  11 in total

Review 1.  Glycomics and glycoproteomics of viruses: Mass spectrometry applications and insights toward structure-function relationships.

Authors:  John F Cipollo; Lisa M Parsons
Journal:  Mass Spectrom Rev       Date:  2020-04-29       Impact factor: 10.946

Review 2.  Mass spectrometry for the identification and analysis of highly complex glycosylation of therapeutic or pathogenic proteins.

Authors:  Yukako Ohyama; Kazuki Nakajima; Matthew B Renfrow; Jan Novak; Kazuo Takahashi
Journal:  Expert Rev Proteomics       Date:  2020-05-28       Impact factor: 3.940

3.  Quantitative assessment of successive carbohydrate additions to the clustered O-glycosylation sites of IgA1 by glycosyltransferases.

Authors:  Tyler J Stewart; Kazuo Takahashi; Nuo Xu; Amol Prakash; Rhubell Brown; Milan Raska; Matthew B Renfrow; Jan Novak
Journal:  Glycobiology       Date:  2021-06-03       Impact factor: 4.313

Review 4.  Glycosylation of viral surface proteins probed by mass spectrometry.

Authors:  Audra A Hargett; Matthew B Renfrow
Journal:  Curr Opin Virol       Date:  2019-06-13       Impact factor: 7.090

Review 5.  Mass Spectrometry-Based Structural Virology.

Authors:  Tobias P Wörner; Tatiana M Shamorkina; Joost Snijder; Albert J R Heck
Journal:  Anal Chem       Date:  2020-12-04       Impact factor: 6.986

6.  Sequential Analysis of the N/O-Glycosylation of Heavily Glycosylated HIV-1 gp120 Using EThcD-sceHCD-MS/MS.

Authors:  Yong Zhang; Shanshan Zheng; Wanjun Zhao; Yonghong Mao; Wei Cao; Wenjuan Zeng; Yueqiu Liu; Liqiang Hu; Meng Gong; Jingqiu Cheng; Younan Chen; Hao Yang
Journal:  Front Immunol       Date:  2021-10-21       Impact factor: 7.561

7.  Vulnerabilities in coronavirus glycan shields despite extensive glycosylation.

Authors:  Yasunori Watanabe; Zachary T Berndsen; Jayna Raghwani; Gemma E Seabright; Joel D Allen; Oliver G Pybus; Jason S McLellan; Ian A Wilson; Thomas A Bowden; Andrew B Ward; Max Crispin
Journal:  Nat Commun       Date:  2020-05-27       Impact factor: 14.919

8.  Proteins mimicking epitope of HIV-1 virus neutralizing antibody induce virus-neutralizing sera in mice.

Authors:  Petr Kosztyu; Milan Kuchar; Jiri Cerny; Lucia Barkocziova; Michal Maly; Hana Petrokova; Lydie Czernekova; Veronika Liskova; Leona Raskova Kafkova; Pavlina Knotigova; Josef Masek; Jaroslav Turanek; Petr Maly; Milan Raska
Journal:  EBioMedicine       Date:  2019-09       Impact factor: 8.143

9.  Quantification of the Resilience and Vulnerability of HIV-1 Native Glycan Shield at Atomistic Detail.

Authors:  Srirupa Chakraborty; Zachary T Berndsen; Nicolas W Hengartner; Bette T Korber; Andrew B Ward; S Gnanakaran
Journal:  iScience       Date:  2020-11-20

10.  Glycan Positioning Impacts HIV-1 Env Glycan-Shield Density, Function, and Recognition by Antibodies.

Authors:  Qing Wei; Audra A Hargett; Barbora Knoppova; Alexandra Duverger; Reda Rawi; Chen-Hsiang Shen; S Katie Farney; Stacy Hall; Rhubell Brown; Brandon F Keele; Sonya L Heath; Michael S Saag; Olaf Kutsch; Gwo-Yu Chuang; Peter D Kwong; Zina Moldoveanu; Milan Raska; Matthew B Renfrow; Jan Novak
Journal:  iScience       Date:  2020-10-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.